Cameron Turtle - Insider Trading & Ownership

Location
C/O Spyre Therapeutics, Inc., 221 Crescent Street, Suite 105, Waltham, MA
Summary
The estimated net worth of Cameron Turtle is at least $20.7M dollars as of December 3, 2025. Cameron Turtle is the Chief Executive Officer, Director of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $20.5M. Cameron Turtle is the Director of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $254K.
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Email me when Turtle Cameron files a new Ownership 3,4,5 report.

⭐ Subscribe ⭐

Ownership of Cameron Turtle

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SYRE Spyre Therapeutics, Inc. Chief Executive Officer, Director $20.5M -$1.49M -6.76% Dec 1, 2025
ORKA Oruka Therapeutics, Inc. Director $254K Jun 2, 2025

Insider Transactions Reported by Cameron Turtle:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.